Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
Filters
Lucy Xiaolu Wang
Assistant Professor of Resource EconomicsUniversity of Massachusetts Amherst
Economics of innovation & digitization in health care markets, particularly in the biopharmaceutical & digital health industries.
Vishesh Agarwal, M.D.
Chair of Addiction Medicine Services, Vice Chair of Department of PsychiatryChristianaCare
Dr. Vishesh Agarwal is an addiction psychiatrist with a demonstrated history of working in the health care industry.
Corinne Kyriacou
Vice Dean of Health Professions and Human Services and Associate Professor of Population HealthHofstra University
Vice Dean for Administration, HPHS and Vice Dean of Health Professions and Human Services and Associate Professor of Population Health
Bruce Armitage
Professor and Co-DirectorCarnegie Mellon University
Bruce Armitage’s current research interests include the use of PNA for sequence-specific recognition of DNA and RNA.
Anton Toutov, Ph.D
Assistant Professor, Department of Chemical and Life Science EngineeringVCU College of Engineering
Dr. Toutov develops new chemical strategies for organic synthesis, catalysis, and medicinal chemistry.
Sima Salahshor
Strategic Advisor | Life Sciences & HealthTech Program ManagementShiruy, Inc | University of Toronto, Faculty of Medicine
Health Innovation Advisory and Program Design & Management
Emily Murphy
Associate Professor of LawUC Hastings College of the Law
Professor Murphy's research focuses on the intersection of neuroscience, behavioral science, and the law.
Jeremy McCallum
Professor of Chemistry & BiochemistryLoyola Marymount University
Seaver College of Science and Engineering
Zhoumeng Lin
Associate ProfessorUniversity of Florida
Zhoumeng Lin’s research is on developing computational models to study nanomedicine, food safety, nanoparticle and chemical risk assessment.
Colin Brenan
CEO and Founder1CellBiO Inc.
Colin Brenan is a serial entrepreneur with expertise in research, project management, and financing of early-stage life science companies.
